NCT02617290 - Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting | Biotech Hunter

Enrollment

1,900

Participants

Timeline

Start Date

January 9, 2017

Primary Completion Date

May 29, 2020

Study Completion Date

September 15, 2020

Conditions

Coronary Artery DiseaseMyocardial IschemiaMyocardial InfarctionStent ThrombosisCardiovascular Diseases

Interventions

DRUG

Ticagrelor

Ticagrelor Loading dose of 180mg given after angiography and before PCI , followed by a 30 days treatment with the maintenance dose of 90mg bid.

DRUG

Clopidogrel

Clopidogrel Loading dose of 300 or 600mg given after angiography and before PCI , followed by a 30 days treatment with the maintenance dose of 75mg per day.

Trial Locations (1)

75013

Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière, Paris